Multivariate - adjusted geometric means of
circulating inflammatory marker concentrations across quintile (Q) categories of partially hydrogenated vegetable oils (PHVOs) and non-hydrogenated vegetable oils (non-HVOs) 1
Relationship of plasma polyunsaturated fatty acids to
circulating inflammatory markers.
This is consistent with reports associating regular exercise with reduced incidence of dementia3 and several cancer types.26 - 28 Potential reasons for improved functional status and survival among regular exercisers may include increased cardiovascular fitness and improved aerobic capacity and organ reserve,29 - 31 increases in skeletal mass and metabolic adaptations of muscle with decreased frailty,29 - 31 lower levels of
circulating inflammatory markers, 32 improved response to vaccinations, 33 and improved higher - order cognitive functions.34
Secondly, carbohydrate consumption has been associated with increased
circulating inflammatory markers, which may depress mood20, 21.
Not exact matches
Several trials have demonstrated that the cardiomyocytes of rodents maintained on IER become more resilient to ischaemic injury induced by occlusion of the left coronary artery 18, 21, 29, which translated into improved long - term survival following such injury in one study.21 In addition, within these studies, associations have been found between the cardiovascular improvements and
markers of oxidative stress 24, 30,
inflammatory responses 18, 24, 29, 30 and increases in
circulating levels of adiponectin.29 Collectively, these reported changes in biochemical and physiological cardiovascular risk factors would be expected to suppress atherosclerotic development and preserve cardiovascular health.
Objective: We assessed the association between consumption of partially hydrogenated vegetable oils (PHVOs) and non-HVOs and
circulating concentrations of
inflammatory markers among Tehrani women aged 40 — 60 y.
Multivariate - adjusted geometric means of
circulating concentrations of
inflammatory markers across quintiles of PHVOs and non-HVOs intakes are shown in Table 3.